Abstract
EudraCT Number: 2012-003056-36
Sponsor Protocol Number: CBAF312A2304
Sponsor Name: Novartis Pharma Services AG
Start Date: 2012-10-31
Medical condition: Secondary progressive multiple sclerosis
Disease:
Version: 21.1
SOC Term: 10029205 - Nervous system disorders
Classification Code: 10063400
Term: Secondary progressive multiple sclerosis
Level: PT
Population Age: Adults
Gender: Male, Female
Trial Protocol: HU (Ongoing), IE (Ongoing), DE (Ongoing), CZ (Ongoing), SK (Completed), NL (Ongoing), ES (Ongoing), GB (GB - no longer in EU/EEA), AT (Ongoing), SE (Ongoing), PT (Ongoing), IT (Ongoing), LV (Ongoing), GR (Ongoing), LT (Ongoing), EE (Ongoing), BE (Ongoing), PL (Ongoing), BG (Ongoing), FR (Ongoing)